A Global Pandemic Remedy to Vaccine Nationalism

Of, Afori; Marcowitz-Bitton, Miriam; Morris, E. Matthew

doi:10.2139/ssrn.3829419

Search citation statements

Order By: Relevance

Paper Sections

Select...

Dear Editor1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

2024

Publication Types

Select...

Article4

Book1

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 5 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Likewise, the human immune system is often unexpected in its responses to various stimuli and difficult to model. 8 So, only about 7% of vaccine candidates can complete preclinical development, and only about 15% to 20% of candidates can go through clinical trials and receive market approval. 9 Considering the feature of vaccine development, governments had to invest in a diverse portfolio to maximise the chances of finding a successful and effective vaccine as quickly as possible.…”

Section: Dear Editormentioning

confidence: 99%